News

Prof. Michael Murrell's group (lead author Zachary Gao Sun, graduate student in physics) in collaboration with Prof. Garegin Papoian's group from the University of Maryland at College Park has found ...
Although the terms brain pliability, brain plasticity, and neuroplasticity are closely tied to the 20th century, the concepts ...
Combining the physical significance of theoretical models with the high fitting accuracy of data-driven models is crucial for precise characterization of fuel cell electric truck (FCET) energy ...
The Langlands programme has inspired and befuddled mathematicians for more than 50 years. A major advance has now opened up new worlds for them to explore.
The biotech bi-weekly: unveiling a single-cell RNA-sequencing kit, scaling up a cell-based mRNA design platform and introducing an optogenetic screening platform for drug discovery 16 Jul 2025 Written ...
Tevogen.AI has launched PredicTcellâ„¢, reducing drug discovery timelines and costs, and expanding into oncology for cancer research.
A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences. The Cell paper demonstrates the platform&rsquo ...
Recent advances in spatial omics and single-cell omics have significantly reshaped biomarker discovery in tumor immunotherapy by addressing critical challenges posed such as tumor heterogeneity ...
A giant gas planet comparable in size to Saturn exists around a small red dwarf star. The discovery is beyond the scope of conventional astronomy theory, and is making experts reconsider ...
New discovery in small primate could pave the way for im-proved stem cell therapies For the first time, researchers have discovered and isolated adult stem cells from a non-human primate.
The FDA today granted accelerated approval to linvoseltamab (Lynozyfic, Regeneron) for adults with relapsed or refractory multiple myeloma who have already received at least four therapeutic regimens.
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing ...